Australia's most trusted
source of pharma news
Posted 21 July 2026 AM
Pharmas promoting GLP-1s are influencing doctors, policy, and perceptions of body image among Indigenous people without addressing the main issues that First Nations people face, Deakin University academics have claimed.
GLP-1 off-label prescriptions and supply shortages have raised equity concerns for First Nations peoples disproportionately affected by diabetes, the authors wrote, while “pharmaceutical companies have simultaneously accelerated their marketing through disease-awareness campaigns, sponsored events and telehealth models, with many campaigns prominently featuring women of colour, including First Nations women.”

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.